OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Circular RNA_ANKIB1 accelerates chemo-resistance of osteosarcoma via binding microRNA-26b-5p and modulating enhancer of zeste homolog 2
Jinshan Tang, Gang Duan, Yunqing Wang, et al.
Bioengineered (2022) Vol. 13, Iss. 3, pp. 7351-7366
Open Access | Times Cited: 14
Jinshan Tang, Gang Duan, Yunqing Wang, et al.
Bioengineered (2022) Vol. 13, Iss. 3, pp. 7351-7366
Open Access | Times Cited: 14
Showing 14 citing articles:
Metal-organic framework-mediated siRNA delivery and sonodynamic therapy for precisely triggering ferroptosis and augmenting ICD in osteosarcoma
Ningxiang Sun, Qingjian Lei, Meng Wu, et al.
Materials Today Bio (2024) Vol. 26, pp. 101053-101053
Open Access | Times Cited: 10
Ningxiang Sun, Qingjian Lei, Meng Wu, et al.
Materials Today Bio (2024) Vol. 26, pp. 101053-101053
Open Access | Times Cited: 10
EZH2: The roles in targeted therapy and mechanisms of resistance in breast cancer
Y. Chen, Hongyan Zhu, Yi Luo, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116624-116624
Open Access | Times Cited: 8
Y. Chen, Hongyan Zhu, Yi Luo, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116624-116624
Open Access | Times Cited: 8
Competitive endogenous network of circRNA, lncRNA, and miRNA in osteosarcoma chemoresistance
Shuang Qin, Yuting Wang, Chunhui Ma, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 16
Shuang Qin, Yuting Wang, Chunhui Ma, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 16
Induction of miR‐224 by Reactive Oxygen Species Regulates RASSF6 and Thus Modulates Malignant Behaviors and Chemosensitivity in Esophageal Squamous Cell Carcinoma
Yi Liu, Yina Wang, Adili Salai, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 3
Open Access
Yi Liu, Yina Wang, Adili Salai, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 3
Open Access
MAT2A inhibits the ferroptosis in osteosarcoma progression regulated by miR-26b-5p
Shuchi Xia, Yun Liang, Yuqing Shen, et al.
Journal of bone oncology (2023) Vol. 41, pp. 100490-100490
Open Access | Times Cited: 10
Shuchi Xia, Yun Liang, Yuqing Shen, et al.
Journal of bone oncology (2023) Vol. 41, pp. 100490-100490
Open Access | Times Cited: 10
New emerging targets in osteosarcoma therapy: PTEN and PI3K/Akt crosstalk in carcinogenesis
Mehrdokht Sadrkhanloo, Mahshid Deldar Abad Paskeh, Mehrdad Hashemi, et al.
Pathology - Research and Practice (2023) Vol. 251, pp. 154902-154902
Closed Access | Times Cited: 10
Mehrdokht Sadrkhanloo, Mahshid Deldar Abad Paskeh, Mehrdad Hashemi, et al.
Pathology - Research and Practice (2023) Vol. 251, pp. 154902-154902
Closed Access | Times Cited: 10
Nanobiotechnological approaches in osteosarcoma therapy: Versatile (nano)platforms for theranostic applications
Yao Jiang, Ke He
Environmental Research (2023) Vol. 229, pp. 115939-115939
Closed Access | Times Cited: 7
Yao Jiang, Ke He
Environmental Research (2023) Vol. 229, pp. 115939-115939
Closed Access | Times Cited: 7
Treating human cancer by targeting EZH2
Mengfei Xu, Chunyan Xu, Rui Wang, et al.
Genes & Diseases (2024) Vol. 12, Iss. 3, pp. 101313-101313
Open Access | Times Cited: 2
Mengfei Xu, Chunyan Xu, Rui Wang, et al.
Genes & Diseases (2024) Vol. 12, Iss. 3, pp. 101313-101313
Open Access | Times Cited: 2
Research progress on the role of lncRNA, circular RNA, and microRNA networks in regulating ferroptosis in osteosarcoma
Chunlu Yan, Yinnan Dou, Ruoliu Xia, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116924-116924
Open Access | Times Cited: 2
Chunlu Yan, Yinnan Dou, Ruoliu Xia, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116924-116924
Open Access | Times Cited: 2
The role of circRNAs in resistance to doxorubicin
Mahla Sanati, Soudeh Ghafouri‐Fard
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Mahla Sanati, Soudeh Ghafouri‐Fard
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Non-coding RNAs in drug and radiation resistance of bone and soft-tissue sarcoma: a systematic review
Huanhuan Chen, Tie‐Ning Zhang, Fang‐Yuan Zhang, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 4
Huanhuan Chen, Tie‐Ning Zhang, Fang‐Yuan Zhang, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 4
Circular RNA ANKIB1 alleviates hypoxia-induced cardiomyocyte injury by modulating miR-452-5p/SLC7A11 axis
Gang Li, Xiaolei Tang, Huaping Tang
Advances in Clinical and Experimental Medicine (2023) Vol. 33, Iss. 3, pp. 261-272
Open Access | Times Cited: 2
Gang Li, Xiaolei Tang, Huaping Tang
Advances in Clinical and Experimental Medicine (2023) Vol. 33, Iss. 3, pp. 261-272
Open Access | Times Cited: 2
Screening of a Prognostic Gene Signature for Relapsed/Refractory Acute Myeloid Leukemia Based on Altered Circulating CircRNA Profiles
Honggang Guo, Yabin Cui, Yanliang Bai, et al.
International Journal of General Medicine (2024) Vol. Volume 17, pp. 2967-2979
Open Access
Honggang Guo, Yabin Cui, Yanliang Bai, et al.
International Journal of General Medicine (2024) Vol. Volume 17, pp. 2967-2979
Open Access
Hsa_circ_0078767 Enhances Osteosarcoma Chemoresistance to Doxorubicin Through the Regulation of the miR-188-3p/GPX4 Axis
Yin Tang, Yuzhe He, L. Wu
Pharmacogenomics and Personalized Medicine (2024) Vol. Volume 17, pp. 511-520
Open Access
Yin Tang, Yuzhe He, L. Wu
Pharmacogenomics and Personalized Medicine (2024) Vol. Volume 17, pp. 511-520
Open Access
